title: HLA and rheumatoid arthritis: how do they connect?
abstract: Rheumatoid arthritis (RA) is a destructive autoimmune disease that mainly affects synovial joints. RA patients can be subdivided in two distinct disease subsets based on the presence of anti-citrullinated protein antibodies (ACPA). These two disease phenotypes are associated with different environmental and genetic risk factors and clinical parameters. The HLA class II locus is the most important risk factor for ACPA-positive RA (ACPA+ RA). ACPA can be found up to 10 years before diagnosis and can be used as a predictive biomarker. During progression from breaking tolerance to a citrullinated protein to ACPA+ RA, the ACPA response matures. Recent work implicates the HLA class II locus as a risk factor in the progression from ACPA positivity to ACPA+ RA. We now propose that this locus directly influences the maturation of the ACPA response, most likely via antigen-specific T-cells providing help to ACPA-producing B-cells allowing for maturation of the citrullinated protein-specific autoantibody response. We present and discuss several models and underlying data, including antibody cross-reactivity, molecular mimicry, and neo-antigen formation, that could explain the HLA-RA connection.
authors.affiliation: Department of Rheumatology, Leiden University Medical Center , Leiden , The Netherlands.
authors.forename: Jurgen
authors.initials: J
authors.lastname: van Heemst
authors.forename: Diane
authors.initials: D
authors.lastname: van der Woude
authors.forename: Tom W
authors.initials: TW
authors.lastname: Huizinga
authors.forename: René E
authors.initials: RE
authors.lastname: Toes
mesh_terms: D000818:Animals; D001172:Arthritis, Rheumatoid / Q000235:genetics / Q000276:immunology / Q000503:physiopathology*; D001323:Autoantibodies / Q000276:immunology; D001402:B-Lymphocytes / Q000276:immunology; D015415:Biomarkers / Q000378:metabolism; D020022:Genetic Predisposition to Disease; D006680:HLA Antigens / Q000276:immunology*; D000949:Histocompatibility Antigens Class II / Q000276:immunology*; D006801:Humans; D010456:Peptides, Cyclic / Q000276:immunology; D012307:Risk Factors
chemical_list: D001323:Autoantibodies; D015415:Biomarkers; D006680:HLA Antigens; D000949:Histocompatibility Antigens Class II; D010456:Peptides, Cyclic; C487763:cyclic citrullinated peptide
keywords: Autoantibodies; CD4-positive T-lymphocytes; autoimmune diseases; histocompatibility antigens class II; rheumatoid arthritis